These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36712063)

  • 21. TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas.
    Maddalena F; Condelli V; Matassa DS; Pacelli C; Scrima R; Lettini G; Li Bergolis V; Pietrafesa M; Crispo F; Piscazzi A; Storto G; Capitanio N; Esposito F; Landriscina M
    Mol Oncol; 2020 Dec; 14(12):3030-3047. PubMed ID: 33025742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial chaperone, TRAP1 as a potential pharmacological target to combat cancer metabolism.
    Ramkumar B; Dharaskar SP; Mounika G; Paithankar K; Sreedhar AS
    Mitochondrion; 2020 Jan; 50():42-50. PubMed ID: 31669620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fyn kinase regulates translation in mammalian mitochondria.
    Koc EC; Miller-Lee JL; Koc H
    Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):533-540. PubMed ID: 27940153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1.
    Kang S; Kang BH
    J Med Chem; 2022 Dec; 65(24):16155-16172. PubMed ID: 36507721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and Inhibitors.
    Joshi A; Ito T; Picard D; Neckers L
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells.
    Masgras I; Sanchez-Martin C; Colombo G; Rasola A
    Front Oncol; 2017; 7():58. PubMed ID: 28405578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
    Kang BH
    BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytosolic Protein Vms1 Links Ribosome Quality Control to Mitochondrial and Cellular Homeostasis.
    Izawa T; Park SH; Zhao L; Hartl FU; Neupert W
    Cell; 2017 Nov; 171(4):890-903.e18. PubMed ID: 29107329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins.
    Amoroso MR; Matassa DS; Laudiero G; Egorova AV; Polishchuk RS; Maddalena F; Piscazzi A; Paladino S; Sarnataro D; Garbi C; Landriscina M; Esposito F
    Cell Death Differ; 2012 Apr; 19(4):592-604. PubMed ID: 21979464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting.
    Masgras I; Laquatra C; Cannino G; Serapian SA; Colombo G; Rasola A
    Semin Cancer Biol; 2021 Nov; 76():45-53. PubMed ID: 34242740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Mitochondrial Hsp90 TRAP1 and Alzheimer's Disease.
    Dekker FA; Rüdiger SGD
    Front Mol Biosci; 2021; 8():697913. PubMed ID: 34222342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties.
    Felts SJ; Owen BA; Nguyen P; Trepel J; Donner DB; Toft DO
    J Biol Chem; 2000 Feb; 275(5):3305-12. PubMed ID: 10652318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FRIENDLY (FMT) is an RNA binding protein associated with cytosolic ribosomes at the mitochondrial surface.
    Hemono M; Salinas-Giegé T; Roignant J; Vingadassalon A; Hammann P; Ubrig E; Ngondo P; Duchêne AM
    Plant J; 2022 Oct; 112(2):309-321. PubMed ID: 36050837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Mitochondrial Protein Expression as a Future Approach for Cancer Therapy.
    Criscuolo D; Avolio R; Matassa DS; Esposito F
    Front Oncol; 2021; 11():797265. PubMed ID: 34888254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
    Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
    Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.
    Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M
    Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localized translation near the mitochondrial outer membrane: An update.
    Lesnik C; Golani-Armon A; Arava Y
    RNA Biol; 2015; 12(8):801-9. PubMed ID: 26151724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRAP1 controls mitochondrial fusion/fission balance through Drp1 and Mff expression.
    Takamura H; Koyama Y; Matsuzaki S; Yamada K; Hattori T; Miyata S; Takemoto K; Tohyama M; Katayama T
    PLoS One; 2012; 7(12):e51912. PubMed ID: 23284813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial chaperone TRAP1 activates the mitochondrial UPR and extends healthspan in Drosophila.
    Baqri RM; Pietron AV; Gokhale RH; Turner BA; Kaguni LS; Shingleton AW; Kunes S; Miller KE
    Mech Ageing Dev; 2014; 141-142():35-45. PubMed ID: 25265088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.
    Li XT; Li YS; Shi ZY; Guo XL
    Life Sci; 2020 Aug; 254():117737. PubMed ID: 32376268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.